Bio-Techne CEO Charles Kummeth's 2019 pay rises 14% to $11.0M

Bio-Techne reports 2019 executive compensation

By ExecPay News

Published: September 9, 2019

Bio-Techne reported fiscal year 2019 executive compensation information on September 9, 2019.
In 2019, five Bio-Techne executives received on average a compensation package of $3.8M, a 19% increase compared to previous year.
Average pay of disclosed executives at Bio-Techne
Charles Kummeth, Chief Executive Officer, received $11M in total, which increased by 14% compared to 2018. 36.33% of Kummeth's compensation, or $4M, was in option awards. Kummeth also received $2M in non-equity incentive plan, $957K in salary, $4M in stock awards, as well as $45.7K in other compensation.
James Hippel, Chief Financial Officer, received a compensation package of $2.8M, which increased by 13% compared to previous year. 43.52% of the compensation package, or $1.2M, was in option awards.
David Eansor, Senior Vice President Biotechnology, earned $2.3M in 2019, a 46% increase compared to previous year.
Kim Kelderman, President, Diagnostics and Genomics, received $1.6M in 2019, which increases by 34% compared to 2018.
Brenda Furlow, General Counsel, earned $1.4M in 2019, a 18% increase compared to previous year.
Bio-Techne's fiscal year ends on June 30.

Related executives

Charles Kummeth


Chief Executive Officer

James Hippel


Chief Financial Officer

David Eansor


Senior Vice President Biotechnology

Kim Kelderman


President, Diagnostics and Genomics

Brenda Furlow


General Counsel

You may also like

Source: SEC filing on September 9, 2019.